In this segment of The Conversation, MPN Edition, Dr. Srdan Verstovsek of MD Anderson Cancer Center, MPN expert Dr. Mark Heaney of Columbia University Cancer Center, and Bob Rosen, Chair of MPN Research Foundation share their insight and views on clinical trial participation. Listen closely as the guests discuss the differences between the REVEAL study and the PEGASYS trial, highlighting the outcomes, reasons, and options for both participation and non-participation in clinical trials and observational studies. As Bob Rosen says, it’s a “balancing act for patients and their doctors to decide.”
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo